These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19397931)

  • 1. Prepulse inhibition and genetic mouse models of schizophrenia.
    Powell SB; Zhou X; Geyer MA
    Behav Brain Res; 2009 Dec; 204(2):282-94. PubMed ID: 19397931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.
    Powell SB; Weber M; Geyer MA
    Curr Top Behav Neurosci; 2012; 12():251-318. PubMed ID: 22367921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation of serotonin receptor function affects prepulse inhibition of the startle.
    Bräuer D; Strobel A; Hensch T; Diers K; Lesch KP; Brocke B
    J Neural Transm (Vienna); 2009 May; 116(5):607-13. PubMed ID: 19352591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia.
    Braff DL
    Curr Top Behav Neurosci; 2010; 4():349-71. PubMed ID: 21312406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic survey of prepulse inhibition in mouse chromosome substitution strains.
    Leussis MP; Frayne ML; Saito M; Berry EM; Aldinger KA; Rockwell GN; Hammer RP; Baskin-Hill AE; Singer JB; Nadeau JH; Sklar P; Petryshen TL
    Genes Brain Behav; 2009 Nov; 8(8):806-16. PubMed ID: 19694817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Realistic expectations of prepulse inhibition in translational models for schizophrenia research.
    Swerdlow NR; Weber M; Qu Y; Light GA; Braff DL
    Psychopharmacology (Berl); 2008 Aug; 199(3):331-88. PubMed ID: 18568339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF Val66Met Genotype Interacts With a History of Simulated Stress Exposure to Regulate Sensorimotor Gating and Startle Reactivity.
    Notaras MJ; Hill RA; Gogos JA; van den Buuse M
    Schizophr Bull; 2017 May; 43(3):665-672. PubMed ID: 27262112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.
    Swerdlow NR; Geyer MA
    Schizophr Bull; 1998; 24(2):285-301. PubMed ID: 9613626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous reeler mice exhibit alterations in sensorimotor gating but not presynaptic proteins.
    Barr AM; Fish KN; Markou A; Honer WG
    Eur J Neurosci; 2008 May; 27(10):2568-74. PubMed ID: 18547243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.
    van den Buuse M
    Schizophr Bull; 2010 Mar; 36(2):246-70. PubMed ID: 19900963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients.
    Csomor PA; Yee BK; Feldon J; Theodoridou A; Studerus E; Vollenweider FX
    Schizophr Bull; 2009 Jan; 35(1):244-55. PubMed ID: 18245063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SPAK knockout on sensorimotor gating, novelty exploration, and brain area-dependent expressions of NKCC1 and KCC2 in a mouse model of schizophrenia.
    Yang SS; Huang CL; Chen HE; Tung CS; Shih HP; Liu YP
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():30-6. PubMed ID: 25797415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
    Kucinski A; Syposs C; Wersinger S; Bencherif M; Stachowiak MK; Stachowiak EK
    Schizophr Res; 2012 Apr; 136(1-3):82-7. PubMed ID: 22285656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y1 receptor.
    Karl T; Chesworth R; Duffy L; Herzog H
    Neuropeptides; 2010 Jun; 44(3):233-9. PubMed ID: 20096928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse genetic models for prepulse inhibition: an early review.
    Geyer MA; McIlwain KL; Paylor R
    Mol Psychiatry; 2002; 7(10):1039-53. PubMed ID: 12476318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction.
    Yee BK; Feldon J
    Behav Brain Res; 2009 Dec; 204(2):387-95. PubMed ID: 19114060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.
    Geyer MA; Krebs-Thomson K; Braff DL; Swerdlow NR
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):117-54. PubMed ID: 11549216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensorimotor gating deficits in "two-hit" models of schizophrenia risk factors.
    Khan A; Powell SB
    Schizophr Res; 2018 Aug; 198():68-83. PubMed ID: 29070440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?
    Karl T; Burne TH; Van den Buuse M; Chesworth R
    Behav Brain Res; 2011 Oct; 223(2):336-41. PubMed ID: 21605597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.
    Kokash J; Alderson EM; Reinhard SM; Crawford CA; Binder DK; Ethell IM; Razak KA
    Brain Res; 2019 Sep; 1719():24-29. PubMed ID: 31128097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.